Lakefront Biotherapeutics (LKFT) Shareholder's Equity (2014 - 2025)

Lakefront Biotherapeutics (LKFT) Shareholder's Equity (2014 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shareholder's Equity (Qtr)
1 Alterity Therapeutics 723,416.35 Bn 723,416.32 Bn - 7.14 Bn
2 Belite Bio 57,340.00 Bn 57,340.00 Bn - 795.79 Mn
3 Quantum Biopharma 19,125.08 Bn 19,125.08 Bn - 595,226.00
4 Legend Biotech 3,262.00 Bn 3,261.71 Bn 242.10 Mn 1.00 Bn
5 Akari Therapeutics 1,789.67 Bn 1,789.67 Bn - 14.38 Mn
6 Evaxion A 1,480.39 Bn 1,480.37 Bn - -
7 Psyence Biomedical 241.78 Bn 241.78 Bn - -
8 Vertex Pharmaceuticals 113.54 Bn 106.29 Bn 2.59 Bn 19.36 Bn
9 Abivax 94.26 Bn 94.26 Bn - 502.95 Mn
10 Lakefront Biotherapeutics 9.64 Bn 9.64 Bn 1.97 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 3.77 Bn
Dec 31, 2024 3.10 Bn
Dec 31, 2023 3.01 Bn
Dec 31, 2022 2.58 Bn
Dec 31, 2021 3.02 Bn
Dec 31, 2020 3.18 Bn
Dec 31, 2019 3.18 Bn
Dec 31, 2018 1.39 Bn
Dec 31, 2017 1.19 Bn
Dec 31, 2016 819.19 Mn
Dec 31, 2015 400.08 Mn
Dec 31, 2014 257.63 Mn